Skip to main content


Annals of Surgical Oncology

Annals of Surgical Oncology 3/2019

Ausgabe 3/2019

Inhaltsverzeichnis ( 32 Artikel )

11.12.2018 | Pancreatic Tumors | Ausgabe 3/2019

Improving Outcomes After Distal Pancreatectomy with Celiac Axis Resection (DP-CAR): As Always, it is All About Patient Selection

Naruhiko Ikoma MD, MS, Matthew H. G. Katz MD

04.01.2019 | PANCREATIC TUMORS | Ausgabe 3/2019

The Value of International Collaboration in Pancreatic Cancer Research: EURECCA

Marc Besselink MD, MSc, PhD

11.01.2019 | Thoracic Oncology | Ausgabe 3/2019

Does Complete Pathologic Response Come to Those Who Wait?

Nicole M. Geissen DO

02.01.2019 | Health Services Research and Global Oncology | Ausgabe 3/2019

What’s Lost in What’s Missing: A Thoughtful Approach to Missing Data in the National Cancer Database

Daniel J. Boffa MD

03.01.2019 | Health Services Research and Global Oncology | Ausgabe 3/2019

Hospital Regional Network Formation and ‘Brand Sharing’: Appearances May Be Deceiving

Bradley N. Reames MD, MS, Daniel A. Anaya MD, Chandrakanth Are MD, MBA

03.01.2019 | Gastrointestinal Oncology | Ausgabe 3/2019

What Constitutes Optimal Management of T1N0 Esophageal Adenocarcinoma?

Fariha H. Ramay MD, MBA, Ashley A. Vareedayah MD, Kavel Visrodia MD, Prasad G. Iyer MD, Kenneth K. Wang MD, Swathi Eluri MD, MSCR, Nicholas J. Shaheen MD, MPH, Rishindra Reddy MD, Linda W. Martin MD, MPH, Bruce D. Greenwald MD, Melanie A. Edwards MD

11.10.2018 | Health Services Research and Global Oncology | Ausgabe 3/2019

Why Travel for Complex Cancer Surgery? Americans React to ‘Brand-Sharing’ Between Specialty Cancer Hospitals and Their Affiliates

Alexander S. Chiu MD, MPH, Benjamin Resio MD, Jessica R. Hoag PhD, Andres F. Monsalve MD, Justin D. Blasberg MD, Lawrence Brown MPH, Audrey Omar MA, Marney A. White PhD, MS, Daniel J. Boffa MD

04.01.2019 | Health Services Research and Global Oncology | Ausgabe 3/2019

Lessons Learned Regarding Missing Clinical Stage in the National Cancer Database

Tanya L. Hoskin MS, Judy C. Boughey MD, Courtney N. Day BS, Elizabeth B. Habermann PhD

07.12.2018 | Health Services Research and Global Oncology | Ausgabe 3/2019

Impact of Long-Course Neoadjuvant Radiation on Postoperative Low Anterior Resection Syndrome and Quality of Life in Rectal Cancer: Post Hoc Analysis of a Randomized Controlled Trial

Weipeng Sun MD, Ruoxu Dou MD, PhD, Jiaohua Chen MD, Sicong Lai MD, Chi Zhang PhD, Lei Ruan BN, Liang Kang MD, Yanhong Deng MD, Ping Lan MD, Lei Wang MD, PhD, Jianping Wang MD, PhD

08.01.2019 | Colorectal Cancer | Ausgabe 3/2019

What is the Best Option Between Primary Diverting Stoma or Endoscopic Stent as a Bridge to Surgery with a Curative Intent for Obstructed Left Colon Cancer? Results from a Propensity Score Analysis of the French Surgical Association Multicenter Cohort of 518 Patients

Diane Mege MD, PhD, Charles Sabbagh MD, PhD, Gilles Manceau MD, PhD, Valérie Bridoux MD, PhD, Zaher Lakkis MD, PhD, Diouf Momar PhD, Igor Sielezneff MD, PhD, Mehdi Karoui MD, PhD, the AFC (French Surgical Association) Working Group

04.01.2019 | Colorectal Cancer | Ausgabe 3/2019

Yield of Colonoscopy in Identification of Newly Diagnosed Desmoid-Type Fibromatosis with Underlying Familial Adenomatous Polyposis

Winan J. van Houdt MD, PhD, Iris H. Wei MD, Deborah Kuk ScM, Li-Xuan Qin PhD, Bhumika Jadeja MS, Anthony Villano MD, Meera Hameed MD, Samuel Singer MD, Aimee M. Crago MD, PhD

04.01.2019 | Hepatobiliary Tumors | Ausgabe 3/2019 Open Access

Outcomes and Risk Score for Distal Pancreatectomy with Celiac Axis Resection (DP-CAR): An International Multicenter Analysis

Sjors Klompmaker MD, Niek A. Peters MD, Jony van Hilst MD, Claudio Bassi MD, Ugo Boggi MD, PhD, Olivier R. Busch MD, PhD, Willem Niesen MD, Thomas M. Van Gulik MD, PhD, Ammar A. Javed MD, Jorg Kleeff MD, FACS, Manabu Kawai MD, PhD, Mickael Lesurtel MD, PhD, Carlo Lombardo MD, A. James Moser MD, FACS, Ken-ichi Okada MD, PhD, Irinel Popescu MD, Raj Prasad MD, Roberto Salvia MD, Alain Sauvanet MD, Christian Sturesson MD, Matthew J. Weiss MD, FACS, Herbert J. Zeh MD, FACS, Amer H. Zureikat MD, FACS, Hiroki Yamaue MD, PhD, Christopher L. Wolfgang MD, MS, PhD, Melissa E. Hogg MD, FACS, Marc G. Besselink MD, PhD, the E-AHPBA DP-CAR study group

09.01.2019 | Hepatobiliary Tumors | Ausgabe 3/2019

Determining the Safety and Efficacy of Enhanced Recovery Protocols in Major Oncologic Surgery: An Institutional NSQIP Analysis

Rebecca K. Marcus MD, Heather A. Lillemoe MD, David C. Rice MB, BCh, BAO, FRCSI, Gabriel Mena MD, Brian K. Bednarski MD, Barbra B. Speer DO, Pedro T. Ramirez MD, Javier D. Lasala MD, Neema Navai MD, Wendell H. Williams MD, Bradford J. Kim MD, MHS, Rachel K. Voss MD, MHS, Vijaya N. Gottumukkala MD, FRCA, Thomas A. Aloia MD, FACS

07.01.2019 | HEPATOBILIARY TUMORS | Ausgabe 3/2019 Open Access

The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy

D. Pereyra, B. Rumpf, M. Ammann MD, S. F. Perrodin MD, D. Tamandl MD, C. Haselmann, J. Stift MD, C. Brostjan PhD, F. Laengle MD, G. Beldi MD, T. Gruenberger MD, P. Starlinger MD, PhD

04.01.2019 | Pancreatic Tumors | Ausgabe 3/2019

Evaluating the Regulatory Immunomodulation Effect of Irreversible Electroporation (IRE) in Pancreatic Adenocarcinoma

Harshul Pandit PhD, Young K. Hong MD, Yan Li MD, PhD, Jack Rostas III, MD, Zachary Pulliam BS, Su Ping Li BS, Robert C. G. Martin MD, PhD, FACS

19.12.2018 | Pancreatic Tumors | Ausgabe 3/2019

Thrombospondin-2 is a Highly Specific Diagnostic Marker and is Associated with Prognosis in Pancreatic Cancer

Hsuan-Yu Peng PhD, Ming-Chu Chang MD, PhD, Chun-Mei Hu PhD, Hwai-I Yang PhD, Wen-Hwa Lee PhD, Yu-Ting Chang MD, MS, PhD

17.12.2018 | Breast Oncology | Ausgabe 3/2019

OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients

S. E. Tevis MD, R. Bassett MS, I. Bedrosian MD, C. H. Barcenas MD, MSc, D. M. Black MD, A. S. Caudle MD, MS, S. M. DeSnyder MD, E. Fitzsullivan MD, K. K. Hunt MD, H. M. Kuerer MD, PhD, A. Lucci MD, F. Meric-Bernstam MD, E. A. Mittendorf MD, PhD, K. Park MD, M. Teshome MD, A. M. Thompson MD, R. F. Hwang MD

07.11.2018 | Reconstructive Oncology | Ausgabe 3/2019

Breast Reconstruction in an Underserved Population: A Retrospective Study

Maxime M. Wang BA, Elizabeth Warnack MD, Kathie-Ann Joseph MD, MPH

23.01.2019 | ASO Author Reflections | Ausgabe 3/2019

ASO Author Reflections: Improving the Rate of Breast Reconstruction in Underserved Populations

Maxime M. Wang BA, Kathie-Ann Joseph MD, MPH

19.12.2018 | Gastrointestinal Oncology | Ausgabe 3/2019

The Therapeutic Survival Benefit of Splenic Hilar Nodal Dissection for Advanced Proximal Gastric Cancer Invading the Greater Curvature

Masahiro Yura MD, Takaki Yoshikawa MD, PhD, Sho Otsuki MD, PhD, Yukinori Yamagata MD, PhD, Shinji Morita MD, PhD, Hitoshi Katai MD, PhD, Toshirou Nishida MD, PhD

07.01.2019 | Gastrointestinal Oncology | Ausgabe 3/2019

Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer

Yasuo Uno MD, Mitsuro Kanda MD, PhD, FACS, Takashi Miwa MD, Shinichi Umeda MD, Haruyoshi Tanaka MD, Chie Tanaka MD, PhD, Daisuke Kobayashi MD, PhD, Masaya Suenaga MD, PhD, Norifumi Hattori MD, PhD, Masamichi Hayashi MD, PhD, Suguru Yamada MD, PhD, FACS, Goro Nakayama MD, PhD, Michitaka Fujiwara MD, PhD, Yasuhiro Kodera MD, PhD, FACS

14.01.2019 | Gastrointestinal Oncology | Ausgabe 3/2019

More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Daniel Solomon MD, Natasha L. DeNicola MD, Yael Feferman MD, Eliahu Bekhor MD, Marina L. Reppucci MD, Daniela Feingold BA, Samantha N. Aycart BS, Deepa R. Magge MD, Benjamin J. Golas MD, Daniel M. Labow MD, Umut Sarpel MD

11.01.2019 | Peritoneal Surface Malignancy | Ausgabe 3/2019

Well-Differentiated Papillary Mesothelioma of the Peritoneum: A Retrospective Study from the RENAPE Observational Registry

Guillaume Vogin MD, PhD, Liza Hettal MSc, Jean-Michel Vignaud MD, PhD, Peggy Dartigues MD, Diane Goere MD, PhD, Gwenaël Ferron MD, PhD, Bruno Heyd MD, PhD, Jean-Marc Bereder MD, Jean-Jacques Tuech MD, PhD, Olivier Glehen MD, PhD, Cécile de Chaisemartin MD, Yoann Lherm MSc, Laurent Villeneuve PhD, Vahan Kepenekian MD, Frédéric Marchal MD, PhD, the RENAPE Network

11.10.2018 | Thoracic Oncology | Ausgabe 3/2019

Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Overall Survival in Esophageal Cancer Patients

Basem Azab MD, Julia R. Amundson MD, Omar Picado MD, Caroline Ripat MD, Francisco Igor Macedo MD, Dido Franceschi MD, Alan S. Livingstone MD, Danny Yakoub MD, PhD

03.01.2019 | Thoracic Oncology | Ausgabe 3/2019

Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung Metastasectomy

Ugo Pastorino MD, Daniele Morelli MD, Giovanni Leuzzi MD, Luigi Rolli MD, Paola Suatoni BS, Francesca Taverna PhD, Elena Bertocchi BL, Mattia Boeri PhD, Gabriella Sozzi PhD, Anna Cantarutti PhD, Giovanni Corrao PhD, Alessandro Gronchi MD

18.12.2018 | Translational Research and Biomarkers | Ausgabe 3/2019

Soluble PD-L1 Expression in Circulation as a Predictive Marker for Recurrence and Prognosis in Gastric Cancer: Direct Comparison of the Clinical Burden Between Tissue and Serum PD-L1 Expression

Tsunehiko Shigemori MD, Yuji Toiyama MD, PhD, FACS, Yoshinaga Okugawa MD, PhD, Akira Yamamoto MD, Chengzeng Yin MD, Aya Narumi MD, Takashi Ichikawa MD, Shozo Ide MD, PhD, Tadanobu Shimura MD, PhD, Hiroyuki Fujikawa MD, PhD, Hiromi Yasuda MD, PhD, Junichiro Hiro MD, PhD, Shigeyuki Yoshiyama MD, PhD, Masaki Ohi MD, PhD, Toshimitsu Araki MD, PhD, Masato Kusunoki MD, PhD

18.12.2018 | Translational Research and Biomarkers | Ausgabe 3/2019

MiR-21 Participates in the PD-1/PD-L1 Pathway-Mediated Imbalance of Th17/Treg Cells in Patients After Gastric Cancer Resection

Xiaoyu Zheng MD, Linlin Dong MD, Kun Wang MD, Huichao Zou MD, Su Zhao MD, Yu Wang MD, Guonian Wang MD, PhD

27.12.2018 | Translational Research and Biomarkers | Ausgabe 3/2019 Open Access

Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography Results in Negative Surgical Margins and Decreased Local Recurrence in an Orthotopic Mouse Model of Osteosarcoma

Adel Mahjoub BA, Alejandro Morales-Restrepo MD, Mitchell S. Fourman MD, M.Phil, Jonathan B. Mandell BA, Lu Feiqi BA, Margaret L. Hankins MD, Rebecca J. Watters PhD, Kurt R. Weiss MD


Effect of c-Met and CD44v6 Expression in Resistance to Chemotherapy in Esophageal Squamous Cell Carcinoma

Takeo Hara MD, Tomoki Makino MD, PhD, Makoto Yamasaki MD, PhD, Koji Tanaka MD, PhD, Yasuhiro Miyazaki MD, PhD, Tsuyoshi Takahashi MD, PhD, Yukinori Kurokawa MD, PhD, Kiyokazu Nakajima MD, PhD, Nariaki Matsuura MD, PhD, Masaki Mori MD, PhD, Yuichiro Doki MD, PhD

04.01.2019 | Translational Research and Biomarkers | Ausgabe 3/2019

Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer

Shinichiro Nakada MD, Satoshi Kuboki MD, Hiroyuki Nojima MD, Hideyuki Yoshitomi MD, Katsunori Furukawa MD, Tsukasa Takayashiki MD, Shigetsugu Takano MD, Masaru Miyazaki MD, Masayuki Ohtsuka MD

03.01.2019 | Gastrointestinal Oncology | Ausgabe 3/2019

Multimodal Treatment of Locally Advanced Gastric Cancer: Will the West Meet the East?

Luigina Graziosi MD, PhD, Elisabetta Marino MD, Annibale Donini MD

04.01.2019 | Gastrointestinal Oncology | Ausgabe 3/2019

Reply to: “Multimodal Treatment of Locally Advanced Gastric Cancer: Will the West Meet the East?”, by Marino, Elisabetta et al.

Yoshiaki Nakamura MD, PhD, Takeharu Yamanaka PhD, Kohei Shitara MD

Aktuelle Ausgaben

Neu im Fachgebiet Chirurgie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Chirurgie und bleiben Sie gut informiert – ganz bequem per eMail.